At the University of Cambridge’s new world-class research facility, the presence of sensitive equipment has made designing ...

The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down. Emerson has ...